• Gamma-linolenic Acid (GLA): Novel Anti-Inflammatory Insights

  2026-05-07

  Explore the advanced anti-inflammatory mechanisms and translational applications of gamma-linolenic acid (GLA), an omega-6 polyunsaturated fatty acid. This cornerstone article reveals new scientific depth and practical protocols, establishing a distinct perspective on GLA’s role in inflammation and disease modeling.

• RNA Pol II Inhibition Triggers Apoptosis via Active Signalin

  2026-05-06

  Harper et al. (2025) reveal that inhibiting RNA polymerase II (Pol II) activates cell death through a regulated apoptotic pathway, independent of loss of gene transcription. This paradigm-shifting insight highlights the importance of Pol II protein integrity and signaling in cellular fate control, with implications for understanding anticancer drug mechanisms.

• A Tunable Human Intestinal Organoid System: Balancing Renewa

  2026-05-06

  This study introduces a human intestinal organoid culture system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule modulators. The approach enables scalable, high-diversity organoid cultures, advancing research in development, disease modeling, and high-throughput applications.

• Chloramphenicol in Plasmid Selection: Workflows & Resistance

  2026-05-05

  Harnessing Chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide) from APExBIO, researchers achieve superior plasmid selection and resistance monitoring. This article translates recent findings on multidrug resistance and plasmid gene dynamics into actionable protocols and troubleshooting tips.

• GSK126 EZH2 Inhibitor: Advanced Workflows in Cancer Epigenet

  2026-05-05

  GSK126 stands out as a selective EZH2 inhibitor, empowering researchers to dissect PRC2-driven gene regulation in cancer and immune contexts. This guide details optimized experimental setups, advanced troubleshooting, and strategic insights that accelerate oncology and immunology discovery using APExBIO’s trusted GSK126.

• Applied Use of (-)-JQ1: Gold Standard Control in BET Inhibit

  2026-05-04

  (-)-JQ1, the inactive JQ1 stereoisomer, is indispensable for rigorous dissection of BET bromodomain inhibitor effects in epigenetics research and cancer biology. This guide translates the latest mechanistic evidence and hands-on workflows into actionable strategies for maximizing assay specificity, reproducibility, and interpretability.

• Heparin Sodium: Advancing Glycosaminoglycan Anticoagulant Re

  2026-05-04

  Heparin sodium from APExBIO empowers translational thrombosis research with unmatched consistency and flexibility—whether for anti-factor Xa activity assays, aPTT measurement, or pioneering nanoparticle delivery models. This article distills workflow-optimized use-cases, troubleshooting, and actionable protocol guidance, drawing on the latest bio-nanovesicle findings.

• Levofloxacin: Synthetic Fluoroquinolone for Advanced Assays

  2026-05-03

  Levofloxacin, a synthetic fluoroquinolone antibiotic, provides researchers with a robust platform for exploring bacterial DNA replication and bone metabolism. This guide delivers applied workflows, troubleshooting tips, and protocol enhancements to maximize the reliability and insight of Levofloxacin-based experiments.

• Ganetespib (STA-9090): Potent Hsp90 Inhibitor for Cancer Res

  2026-05-02

  Ganetespib (STA-9090) is a triazolone-containing small molecule that disrupts Hsp90 function, leading to degradation of oncogenic client proteins. It exhibits nanomolar potency in multiple cancer cell lines and has shown robust tumor regression in preclinical xenograft models. This article details its mechanism, benchmarks, and workflow integration for translational cancer research.

• Applied Insights: EdU Flow Cytometry Assay Kits (Cy3) in Cel

  2026-05-02

  EdU Flow Cytometry Assay Kits (Cy3) deliver denaturation-free, highly sensitive DNA synthesis detection for streamlined cell proliferation and genotoxicity workflows. This article translates recent mechanistic research into actionable, stepwise protocols and troubleshooting strategies, highlighting how APExBIO’s kit empowers robust cell cycle analysis and multiplexed experimental designs.

• Breast Cancer’s Dependence on MCL-1: Apoptosis as the Key Ta

  2026-05-01

  This study rigorously demonstrates that MCL-1’s canonical anti-apoptotic function is essential for breast cancer survival and progression. Using genetic and pharmacological strategies, the authors decisively show that targeting MCL-1 with BH3-mimetic drugs impedes tumor growth, with effects strictly dependent on the mitochondrial apoptosis pathway.

• Strategic Innovation with Amiloride (MK-870) in Translationa

  2026-04-30

  This article delivers a thought-leadership perspective on Amiloride (MK-870) as a cornerstone for translational ion channel and receptor pathway research. By blending mechanistic depth with actionable protocol guidance, it contextualizes the compound's pivotal role in bridging fundamental discovery and clinical application—highlighting competitive advantages, translational implications, and a forward-looking outlook.

• Cy7 NHS Ester: Practical Guide for Near-Infrared Protein Lab

  2026-04-30

  Cy7 NHS ester addresses the need for robust, hydrophilic near-infrared labeling of proteins and peptides, especially in sensitive in vitro and in vivo imaging workflows. Its sulfonated structure minimizes dye aggregation and denaturation risks, but it is not suited for long-term solution storage or non-amine labeling. The product is best used where high water solubility and minimal background are critical.

• 20-HETE–TRPV1–MrgprA3+ Axis Drives Allokinesis in Chronic De

  2026-04-29

  The referenced study reveals that elevated 20-HETE activates TRPV1 channels on MrgprA3+ neurons, driving itch (allokinesis) in chronic dermatitis. This mechanistic link provides a potential therapeutic target for chronic itch, with implications for sensory neuron research and translational models.

• Aneugen Mechanism Profiling: Insights from 27 Reference Comp

  2026-04-29

  This paper introduces a robust tiered assay to differentiate molecular mechanisms underlying chemical-induced aneugenicity, focusing on tubulin modulation and mitotic kinase inhibition. The findings establish a reliable framework for mechanistic genotoxicity assessment, with implications for antifungal and antimitotic drug discovery.

421 records 17/29 page Previous Next First page 上5页 1617181920 下5页 Last page